Amicus Therapeutics Inc
NASDAQ:FOLD

Watchlist Manager
Amicus Therapeutics Inc Logo
Amicus Therapeutics Inc
NASDAQ:FOLD
Watchlist
Price: 11.42 USD -1.38% Market Closed
Market Cap: 3.4B USD
Have any thoughts about
Amicus Therapeutics Inc?
Write Note

Amicus Therapeutics Inc
Net Issuance of Common Stock

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Amicus Therapeutics Inc
Net Issuance of Common Stock Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Net Issuance of Common Stock Analysis
Latest Figures & CAGR of Competitors

Company Net Issuance of Common Stock CAGR 3Y CAGR 5Y CAGR 10Y
Amicus Therapeutics Inc
NASDAQ:FOLD
Net Issuance of Common Stock
$76.6m
CAGR 3-Years
10%
CAGR 5-Years
-17%
CAGR 10-Years
9%
Abbvie Inc
NYSE:ABBV
Net Issuance of Common Stock
-$1.1B
CAGR 3-Years
-11%
CAGR 5-Years
21%
CAGR 10-Years
-16%
Gilead Sciences Inc
NASDAQ:GILD
Net Issuance of Common Stock
-$690m
CAGR 3-Years
-19%
CAGR 5-Years
23%
CAGR 10-Years
9%
Amgen Inc
NASDAQ:AMGN
Net Issuance of Common Stock
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Net Issuance of Common Stock
-$584.3m
CAGR 3-Years
-2%
CAGR 5-Years
-35%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Net Issuance of Common Stock
-$41.4m
CAGR 3-Years
52%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Amicus Therapeutics Inc's Net Issuance of Common Stock?
Net Issuance of Common Stock
76.6m USD

Based on the financial report for Jun 30, 2024, Amicus Therapeutics Inc's Net Issuance of Common Stock amounts to 76.6m USD.

What is Amicus Therapeutics Inc's Net Issuance of Common Stock growth rate?
Net Issuance of Common Stock CAGR 10Y
9%

Over the last year, the Net Issuance of Common Stock growth was 129%. The average annual Net Issuance of Common Stock growth rates for Amicus Therapeutics Inc have been 10% over the past three years , -17% over the past five years , and 9% over the past ten years .

Back to Top